Sprix FDA Approval History
FDA Approved: Yes (First approved May 14, 2010)
Brand name: Sprix
Generic name: ketorolac tromethamine
Dosage form: Nasal Spray
Previous Name: ROX-888
Company: Egalet Corporation
Treatment for: Pain
Sprix (ketorolac tromethamine) is an intranasal analgesic for the management of acute moderate to severe pain.
Development timeline for Sprix
| Date | Article |
|---|---|
| May 17, 2010 | Approval Roxro Announces FDA Approval of Sprix |
| Feb 6, 2009 | Roxro Announces FDA Accepts for Review NDA for ROX-888 for the Management of Acute Moderate to Severe Pain |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.